Benjamin Daniels
YOU?
Author Swipe
View article: 829 Predictors of Operative Length in Colorectal Cancer Surgery: A Retrospective Review
829 Predictors of Operative Length in Colorectal Cancer Surgery: A Retrospective Review Open
Aim The duration of colorectal cancer (CRC) surgery is a critical consideration in surgical planning, directly affecting patient outcomes. Longer operative times are associated with an increased risk of complications. This study aims to id…
View article: Systematic Evaluation of Australian Risk Management Plans for Biologic Medicines
Systematic Evaluation of Australian Risk Management Plans for Biologic Medicines Open
View article: Are Technology Adoption Subsidies Really so Unfair?
Are Technology Adoption Subsidies Really so Unfair? Open
View article: From lawns to meadows: spiders (Arachnida: Araneae) as indicators to measure urban grassland restoration success
From lawns to meadows: spiders (Arachnida: Araneae) as indicators to measure urban grassland restoration success Open
In the present study, we investigate how spiders can be used to assess the effectiveness of restoring mesic grasslands on former urban lawns. We compile and analyze a comprehensive dataset, including both past and current data, focusing on…
View article: The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia
The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia Open
Background The Medicines Intelligence (MedIntel) Data Platform is an anonymised linked data resource designed to generate real‐world evidence on prescribed medicine use, effectiveness, safety, costs and cost‐effectiveness in Australia. Res…
View article: Trajectories of Opioid Use Before and After Cancer Diagnosis: A Population-Based Cohort Study
Trajectories of Opioid Use Before and After Cancer Diagnosis: A Population-Based Cohort Study Open
There is considerable heterogeneity in opioid use before and after cancer diagnosis. Our findings suggest noncancer factors drive a significant proportion of postdiagnosis opioid use, but use increased significantly from the month of cance…
View article: Metabolic Resistance and Not Voltage-Gated Sodium Channel Gene Mutation Is Associated with Pyrethroid Resistance of Aedes albopictus (Skuse, 1894) from Cambodia
Metabolic Resistance and Not Voltage-Gated Sodium Channel Gene Mutation Is Associated with Pyrethroid Resistance of Aedes albopictus (Skuse, 1894) from Cambodia Open
(1) Background: In Cambodia, Aedes albopictus is an important vector of the dengue virus. Vector control using insecticides is a major strategy implemented in managing mosquito-borne diseases. Resistance, however, threatens to undermine th…
View article: The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia
The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia Open
The Medicines Intelligence (MedIntel) Data Platform is an anonymised linked data resource designed to generate real-world evidence on prescribed medicine use, safety, costs and cost-effectiveness in Australia. The platform comprises Medica…
View article: The impact of tightened prescribing restrictions for <scp>PBS</scp>‐subsidised opioid medicines and the introduction of half‐pack sizes, Australia, 2020–21: an interrupted time series analysis
The impact of tightened prescribing restrictions for <span>PBS</span>‐subsidised opioid medicines and the introduction of half‐pack sizes, Australia, 2020–21: an interrupted time series analysis Open
Objectives To evaluate the impact of the tightened Pharmaceutical Benefits Scheme (PBS) prescribing rules for immediate release (IR) and controlled release (CR) opioid medicines (1 June 2020), which also eliminated repeat dispensing withou…
View article: Cryptic genetic adaptation despite high gene flow in a range-expanding population
Cryptic genetic adaptation despite high gene flow in a range-expanding population Open
Signals of natural selection can be quickly eroded in high gene-flow systems, severely challenging efforts to understand how and when genetic adaptation occurs in the ocean. This long-standing, unresolved topic in ecology has renewed impor…
View article: Medicine utilization studies in Australian individual‐level dispensing data: A blinded, multi‐center replicated analysis
Medicine utilization studies in Australian individual‐level dispensing data: A blinded, multi‐center replicated analysis Open
Purpose Medicine dispensing data require extensive preparation when used for research and decisions during this process may lead to results that do not replicate between independent studies. We conducted an experiment to examine the impact…
View article: Changes in systemic cancer therapy in Australia during the Delta and Omicron waves of the COVID-19 pandemic (2021–2022): a controlled interrupted time series analysis
Changes in systemic cancer therapy in Australia during the Delta and Omicron waves of the COVID-19 pandemic (2021–2022): a controlled interrupted time series analysis Open
Objectives:Australian lockdowns in response to the initial coronavirus disease 2019 (COVID-19) outbreak in 2020 were associated with small and transient changes in the use of systemic cancer therapy. We aimed to investigate the impacts of …
View article: Supplementary Figure S2 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Supplementary Figure S2 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Supplementary Figure S2: Study flowchart showing the number of women with a first diagnosis of primary invasive breast cancer in New South Wales in 2001-2002 and 2006-2007, number included in the study cohorts, and reasons for exclusions.
View article: Supplementary Figure S4 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Supplementary Figure S4 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Supplementary Figure S4: Cumulative incidence of distant recurrence (%) among 6598 women diagnosed with non-metastatic breast cancer in New South Wales, 2006-2007, and distant recurrence-free at 12 months, stratified by treatment-defined E…
View article: Supplementary Table S3 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Supplementary Table S3 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Supplementary Table S3: Cumulative incidence of distant recurrence (%) and absolute risk difference at 5 and 9 years after breast cancer diagnosis, 2001-2002 and 2006-2007 cohorts, by area-level socioeconomic status (more disadvantaged, le…
View article: Data from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Data from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Background:We investigated differences in cumulative incidence of first distant recurrence (DR) following non-metastatic breast cancer over a time period when new adjuvant therapies became available in Australia.Methods:We conducted a heal…
View article: Supplementary Figure S1 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Supplementary Figure S1 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Supplementary Figure S1: Timeline of Pharmaceutical Benefits Scheme subsidization of adjuvant taxanes and targeted therapies for breast cancer in Australia, 1995-2016.
View article: Supplementary Figure S4 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Supplementary Figure S4 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Supplementary Figure S4: Cumulative incidence of distant recurrence (%) among 6598 women diagnosed with non-metastatic breast cancer in New South Wales, 2006-2007, and distant recurrence-free at 12 months, stratified by treatment-defined E…
View article: Supplementary Table S1 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Supplementary Table S1 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Supplementary Table S1: Data sources and criteria for classifying distant recurrence from administrative health records.
View article: Supplementary Figure S3 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Supplementary Figure S3 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Supplementary Figure S3: Annual hazard rate of first distant recurrence (%) among 16,521 women diagnosed with non-metastatic breast cancer in New South Wales, 2001–2002 and 2006– 2007, stratified by cohort and categorized by extent of dise…
View article: Supplementary Table S2 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Supplementary Table S2 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Supplementary Table S2: Adjuvant therapy dispensed for breast cancer distant recurrence-free at 12 months after diagnosis, 2006–2007 cohort, by area-level socioeconomic status (more disadvantaged, less disadvantaged), and categorized by ex…
View article: Supplementary Figure S1 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Supplementary Figure S1 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Supplementary Figure S1: Timeline of Pharmaceutical Benefits Scheme subsidization of adjuvant taxanes and targeted therapies for breast cancer in Australia, 1995-2016.
View article: Supplementary Table S1 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Supplementary Table S1 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Supplementary Table S1: Data sources and criteria for classifying distant recurrence from administrative health records.
View article: Data from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Data from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Background:We investigated differences in cumulative incidence of first distant recurrence (DR) following non-metastatic breast cancer over a time period when new adjuvant therapies became available in Australia.Methods:We conducted a heal…
View article: Supplementary Table S3 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Supplementary Table S3 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Supplementary Table S3: Cumulative incidence of distant recurrence (%) and absolute risk difference at 5 and 9 years after breast cancer diagnosis, 2001-2002 and 2006-2007 cohorts, by area-level socioeconomic status (more disadvantaged, le…
View article: Supplementary Figure S3 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Supplementary Figure S3 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Supplementary Figure S3: Annual hazard rate of first distant recurrence (%) among 16,521 women diagnosed with non-metastatic breast cancer in New South Wales, 2001–2002 and 2006– 2007, stratified by cohort and categorized by extent of dise…
View article: Supplementary Figure S2 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Supplementary Figure S2 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Supplementary Figure S2: Study flowchart showing the number of women with a first diagnosis of primary invasive breast cancer in New South Wales in 2001-2002 and 2006-2007, number included in the study cohorts, and reasons for exclusions.
View article: Supplementary Table S2 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016
Supplementary Table S2 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 Open
Supplementary Table S2: Adjuvant therapy dispensed for breast cancer distant recurrence-free at 12 months after diagnosis, 2006–2007 cohort, by area-level socioeconomic status (more disadvantaged, less disadvantaged), and categorized by ex…
View article: Characteristics and post-metastasis survival of recurrent metastatic breast cancer over time – An Australian population-based record linkage study, 2001–2016
Characteristics and post-metastasis survival of recurrent metastatic breast cancer over time – An Australian population-based record linkage study, 2001–2016 Open
Despite less favourable prognostic characteristics in C2, BC-related survival following rMBC was similar between the two cohorts; and improved for women with HER2-positive tumours. These findings support the real-world benefits of newer tr…
View article: 1687O PRIMCAT: A novel approach to informing health technology assessment decision making in Australia
1687O PRIMCAT: A novel approach to informing health technology assessment decision making in Australia Open